Prime Medicine Inc. (PRME) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Prime Medicine Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$5.36
+23.22% today
Market cap
$789M
Overall quality
—
Kronos AI 30-day
−26.9%
0 of 8 simulated paths end higher
Prime Medicine Inc. (PRME) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $789M. It trades at $5.36, up 23.22% today. 8 analysts' average target of $7.67 implies +43.1% from today's price. Kronos AI's 30-day forecast is −26.9% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.67 |
| Low – high | $5.00 – $11.00 |
| Analysts | 8 |
| Upside to average | +43.1% |
Kronos AI 30-day forecast
| Expected close | $3.18 (−26.9%) |
| Likely range | −32.1% … −21.7% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.